首页|期刊导航|护理研究|癌症病人共享决策准备度问卷的汉化及信效度检验

癌症病人共享决策准备度问卷的汉化及信效度检验OA

Sinicization and raliability and validity test of the Patient Readiness for Shared Decision-Making Questionnaire for Cancer Patients(ReadySDM)

中文摘要英文摘要

目的:汉化癌症病人共享决策准备度问卷(Patient Readiness for SDM Questionnaire,ReadySDM)并检验其在国内癌症病人中的信效度.方法:成立研究小组,使用Brislin翻译模型对原问卷进行直译、回译、跨文化调适和预调查,最终形成中文版ReadySDM.选取郑州市某三级甲等医院的383例癌症病人进行问卷调查,评价中文版ReadySDM的信效度.结果:探索性因子分析共提取4个公因子,累计方差贡献率为70.063%;验证性因子分析显示模型拟合较好.形成的中文版ReadySDM包括治疗方案信息、与医护人员沟通情况、决策过程的感受与体验、决策偏好与意愿4个维度,共18个条目.问卷条目水平的内容效度指数为0.875~1.000,量表水平的内容效度指数为0.988;问卷总Cronbach's α系数为0.927,折半信度系数为0.809.结论:中文版ReadySDM具有较好的信效度和实用性,适用于评估中国癌症病人的共享决策准备度,可为临床推进共享决策实践提供有效工具.

Objective:To translate the Patient Readiness for Shared Decision-Making Questionnaire(ReadySDM)into Chinese and to test its reliability and validity among cancer patients in China.Methods:A research team was formed.The original questionnaire underwent forward translation,back-translation,cross-cultural adaptation,and a pilot study following the Brislin translation model,culminating in the Chinese version of the ReadySDM.A survey was conducted among 383 cancer patients from a tertiary hospital in Zhengzhou to evaluate the reliability and validity of the Chinese version of the ReadySDM.Results:Exploratory factor analysis extracted four common factors,explaining 70.063%of the total variance.Confirmatory factor analysis indicated a good model fit.The finalized Chinese version of the ReadySDM comprises 18 items across four dimensions:Information on Treatment Options,Communication with Healthcare Providers,Feelings and Experiences in the Decision-Making Process,and Decision-Making Preferences and Willingness.The item-level content validity index ranged from 0.875 to 1.000,and the scale-level content validity index was 0.988.The overall Cronbach's α coefficient for the questionnaire was 0.927,and the split-half reliability coefficient was 0.809.Conclusions:The Chinese version of the ReadySDM demonstrates good reliability,validity,and practicality.It is suitable for assessing the readiness for shared decision-making among Chinese cancer patients and can serve as an effective tool to advance shared decision-making practices in clinical settings.

温雅颖;焦春辉;石伟玲;李颖颖;杨程舒;何卫芳;屈清荣

郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052郑州大学第一临床医学院,河南 450052

癌症共享决策决策参与信度效度评估工具

cancershared decision-makingdecision participationreliabilityvalidityassessment tool

《护理研究》 2026 (9)

1534-1541,8

河南省高等学校重点科研项目,编号:23A320048,24A320054

10.12102/j.issn.1009-6493.2026.09.014

评论